Aspira Womens Health Inc
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitiv… Read more
Aspira Womens Health Inc (AWH) - Total Assets
Latest total assets as of December 2024: $5.49 Million USD
Based on the latest financial reports, Aspira Womens Health Inc (AWH) holds total assets worth $5.49 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Aspira Womens Health Inc - Total Assets Trend (1998–2024)
This chart illustrates how Aspira Womens Health Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Aspira Womens Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Aspira Womens Health Inc's total assets of $5.49 Million consist of 76.2% current assets and 23.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 32.2% |
| Accounts Receivable | $990.00K | 18.0% |
| Inventory | $326.00K | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1998–2024)
This chart illustrates how Aspira Womens Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aspira Womens Health Inc's current assets represent 76.2% of total assets in 2024, an increase from 62.8% in 1998.
- Cash Position: Cash and equivalents constituted 32.2% of total assets in 2024, down from 62.8% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1998.
- Asset Diversification: The largest asset category is accounts receivable at 18.0% of total assets.
Aspira Womens Health Inc Competitors by Total Assets
Key competitors of Aspira Womens Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Aspira Womens Health Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Aspira Womens Health Inc generates 1.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Aspira Womens Health Inc is currently not profitable relative to its asset base.
Aspira Womens Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.76 | 1.03 | 3.37 |
| Quick Ratio | 0.71 | 0.99 | 3.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.28 Million | $ 161.00K | $ 9.43 Million |
Aspira Womens Health Inc - Advanced Valuation Insights
This section examines the relationship between Aspira Womens Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.02 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -12.3% |
| Total Assets | $5.49 Million |
| Market Capitalization | $664.47K USD |
Valuation Analysis
Below Book Valuation: The market values Aspira Womens Health Inc's assets below their book value (0.12 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Aspira Womens Health Inc's assets decreased by 12.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aspira Womens Health Inc (1998–2024)
The table below shows the annual total assets of Aspira Womens Health Inc from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $5.49 Million | -12.31% |
| 2023-12-31 | $6.26 Million | -63.96% |
| 2022-12-31 | $17.37 Million | -57.71% |
| 2021-12-31 | $41.08 Million | +109.53% |
| 2020-12-31 | $19.61 Million | +41.78% |
| 2019-12-31 | $13.83 Million | +21.21% |
| 2018-12-31 | $11.41 Million | +52.17% |
| 2017-12-31 | $7.50 Million | -6.51% |
| 2016-12-31 | $8.02 Million | -61.74% |
| 2015-12-31 | $20.96 Million | -13.30% |
| 2014-12-31 | $24.17 Million | -21.10% |
| 2013-12-31 | $30.64 Million | +254.88% |
| 2012-12-31 | $8.63 Million | -62.64% |
| 2011-12-31 | $23.11 Million | -3.84% |
| 2010-12-31 | $24.04 Million | +421.48% |
| 2009-12-31 | $4.61 Million | +19.47% |
| 2008-12-31 | $3.86 Million | -83.96% |
| 2007-12-31 | $24.05 Million | +4.51% |
| 2006-12-31 | $23.02 Million | -56.42% |
| 2005-12-31 | $52.81 Million | -29.00% |
| 2004-12-31 | $74.38 Million | -27.10% |
| 2003-12-31 | $102.03 Million | +16.45% |
| 2002-12-31 | $87.61 Million | -17.98% |
| 2001-12-31 | $106.82 Million | -10.20% |
| 2000-12-31 | $118.95 Million | +1637.99% |
| 1999-12-31 | $6.84 Million | -38.59% |
| 1998-12-31 | $11.14 Million | -- |